Evidence map›Paper›PMID 22932003›Full record

ArticlePhysical biology2012

Interplay between desolvation and secondary structure in mediating cosolvent and temperature induced alpha-synuclein aggregation.

V L Anderson, W W Webb, D Eliezer

Abstract read
In one paragraph

Article in Physical biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

V L AndersonSchool of Applied and Engineering Physics, Cornell University, Ithaca, NY, USA.
W W Webb
D Eliezer

Funding

Structure and Function of Alpha-SynucleinR37AG019391 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELIEZER, DAVID · 2010 to 2019
$3.4M
Structure and Function of Alpha-SynucleinR01AG019391 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELIEZER, DAVID · 2001 to 2009
$2.6M
Structure and Function of TauR01AG025440 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELIEZER, DAVID · 2005 to 2008
$1.2M
Nascent Dynamic Intermediates in Amyloid AggregationR21AG026650 · NIA · CORNELL UNIVERSITY ITHACA · PI WEBB, WATT W · 2005 to 2006
$365k
NIA NIH HHS 5 R21 AG026650NIA NIH HHS AG019391NIA NIH HHS AG025440NIA NIH HHS R01 AG019391NIA NIH HHS R01 AG025440NIA NIH HHS R21 AG026650NIA NIH HHS R37 AG019391
6 · The paper itself

Abstract

Both increased temperature and moderate concentrations of fluorinated alcohols enhance aggregation of the Parkinson's disease-associated protein α-synuclein (αS). Here, we investigate the secondary structural rearrangements induced by heating and trifluoroethanol [TFE]. At low TFE concentrations, CD spectra feature a negative peak characteristic of disordered polypeptides near 200 nm and a slight shoulder around 220 nm suggesting some polyproline-II content. Upon heating, these peaks weaken, while a weak negative signal develops at 222 nm. At high TFE concentrations, the spectra show distinct minima at 208 and 222 nm, indicative of considerable α-helical structure, which diminish upon heating. We observe a crossover between the low-TFE and high-TFE behavior near 15% TFE, where we previously showed that a partially helical intermediate is populated. We postulate that the protein is well solvated by water at low TFE concentrations and by TFE at high TFE concentrations, but may become desolvated at the crossover point. We discuss the potential roles and interplay of desolvation and helical secondary structure in driving αS aggregation.

Indexed as

alpha-SynucleinCircular DichroismMicroscopy, Electron, TransmissionProtein Structure, SecondaryTemperatureTrifluoroethanolalpha-SynucleinTrifluoroethanol

Identifiers

PMID22932003
PMCPMC3588587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.